FIELD: medicine.
SUBSTANCE: there are used chymotrypsin 360-480 mg/day, trypsin 360-480 mg/day, papaine 900-1200 mg/day and 1,9-dihydro-9-beta-D-ribofuranosyl-6H-purin-6-one (Inosine) 1200-1800 mg/day, zinc 7-10 mg/day, selenium 50-100 mcg/day, vitamin E - 30-400 mg/day, C - 180-500 mg/day, B-carotin - 4-10 mg/day taken orally for 2-3 weeks during a female's follicular phase.
EFFECT: method enables reducing the binding of sperm-coating antibodies to sperm cells and improving the quantitative measures of the semen analysis through the complex immunomodulatory, proteolytic, inflammatory, antioxidant, antihypoxic and anabolic effects.
1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PHARMACOLOGICAL TREATMENT OF AUTOIMMUNE MALE STERILITY | 1998 |
|
RU2149021C1 |
METHOD OF TREATING IMMUNE MALE STERILITY | 2010 |
|
RU2421220C1 |
METHOD OF TREATING AUTOIMMUNE MALE STERILITY | 2010 |
|
RU2430725C1 |
METHOD FOR TREATING AUTOIMMUNE MALE INFERTILITY | 1998 |
|
RU2155596C2 |
METHOD FOR PREDICTION OF MALE REPRODUCTIVE FUNCTION NORMALISATION FOLLOWING VARICOCELECTOMY | 2012 |
|
RU2519185C1 |
METHOD FOR PREDICTION OF EFFICIENCY OF LOW-INTENSITY LASER THERAPY IN AUTOIMMUNE INFERTILITY IN MEN | 2020 |
|
RU2752994C1 |
METHOD FOR APPLYING CRYOPLSMASORPTION | 2003 |
|
RU2238110C1 |
METHOD FOR TREATING AUTOIMMUNE MALE INFERTILITY CASES | 2005 |
|
RU2294779C1 |
PROGNOSTIC METHOD FOR FERTILITY DISORDERS IN MEN | 2006 |
|
RU2342660C2 |
RECTAL MEDICINAL AGENT FOR CORRECTION OF SPERMATOGENESIS DISORDERS IN MALE INFERTILITY | 2017 |
|
RU2686334C2 |
Authors
Dates
2014-05-27—Published
2012-12-13—Filed